Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of Mycobacterium tuberculosis Dihydrofolate Reductase
- 14 August 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 12 (9) , 2448-2456
Abstract
Though phenotypic and target-based high-throughput screening approaches have been employed to discover new antibiotics, the identification of promising therapeutic candidates remains challenging. Each approach provides different information, and understanding their results can provide hypotheses for a mechanism of action (MoA) and reveal actionable chemical matter. Here, we describe a framework for identifying efficacy targets of bioactive compounds. High throughput biophysical profiling against a broad range of targets coupled with machine learning was employed to identify chemical features with predicted efficacy targets for a given phenotypic screen. We validate the approach on data from a set of 55 000 compounds in 24 historical internal antibacterial phenotypic screens and 636 bacterial targets screened in high-throughput biophysical binding assays. Models were built to reveal the relationships between phenotype, target, and chemotype, which recapitulated mechanisms for known antibacterials. We also prospectively identified novel inhibitors of dihydrofolate reductase with nanomolar antibacterial efficacy against Mycobacterium tuberculosis. Molecular modeling provided structural insight into target–ligand interactions underlying selective killing activity toward mycobacteria over human cells.Keywords
Funding Information
- Division of Intramural Research
- National Institute of Allergy and Infectious Diseases (HHSN272200700058C, HHSN272201200025C, HHSN272201200026C)
This publication has 34 references indexed in Scilit:
- The evolutionary rate of antibacterial drug targetsBMC Bioinformatics, 2013
- Large-scale prediction and testing of drug activity on side-effect targetsNature, 2012
- Extended-Connectivity FingerprintsJournal of Chemical Information and Modeling, 2010
- Enrichment of High-Throughput Screening Data with Increasing Levels of Noise Using Support Vector Machines, Recursive Partitioning, and Laplacian-Modified Naive Bayesian ClassifiersJournal of Chemical Information and Modeling, 2005
- Deriving Knowledge through Data Mining High-Throughput Screening DataJournal of Medicinal Chemistry, 2004
- Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugsJournal of Molecular Biology, 2000
- Comparison of Two Independent Crystal Structures of Human Dihydrofolate Reductase Ternary Complexes Reduced with Nicotinamide Adenine Dinucleotide Phosphate and the Very Tight-Binding Inhibitor PT523,Biochemistry, 1997
- Optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductaseJournal of Medicinal Chemistry, 1991
- A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice1981
- Dihydrofolate Reductase: X-ray Structure of the Binary Complex with MethotrexateScience, 1977